170 related articles for article (PubMed ID: 6274376)
1. Experimental ulcerative herpetic keratitis. IV. Preliminary observations on the efficacy of a herpes simplex subunit vaccine.
Carter CA; Hartley CE; Skinner GR; Turner SP; Easty DL
Br J Ophthalmol; 1981 Oct; 65(10):679-82. PubMed ID: 6274376
[TBL] [Abstract][Full Text] [Related]
2. Protection from experimental ocular herpetic keratitis by a heat-killed virus vaccine.
Metcalf JF
Arch Ophthalmol; 1980 May; 98(5):893-6. PubMed ID: 6246863
[TBL] [Abstract][Full Text] [Related]
3. Investigation of a sub-unit vaccine using an animal model of herpes simplex keratitis.
Harney BA; Easty DL; Skinner GR
Trans Ophthalmol Soc U K (1962); 1983; 103 ( Pt 3)():342-6. PubMed ID: 6324419
[TBL] [Abstract][Full Text] [Related]
4. Experimental ulcerative herpetic keratitis. I. Systemic immune responses and resistance to corneal infection.
Carter C; Easty DL
Br J Ophthalmol; 1981 Feb; 65(2):77-81. PubMed ID: 6257272
[TBL] [Abstract][Full Text] [Related]
5. A therapeutic vaccine that reduces recurrent herpes simplex virus type 1 corneal disease.
Nesburn AB; Burke RL; Ghiasi H; Slanina SM; Wechsler SL
Invest Ophthalmol Vis Sci; 1998 Jun; 39(7):1163-70. PubMed ID: 9620075
[TBL] [Abstract][Full Text] [Related]
6. [Dynamics of cellular immunity indices in patients with ophthalmic herpes treated with a herpetic polyvaccine].
Barinskiĭ IF; Blokha VV; Bukovskaia SN; Belokrinitskiĭ DV; Belkina IV
Vopr Virusol; 1988; 33(2):212-7. PubMed ID: 2842963
[TBL] [Abstract][Full Text] [Related]
7. Ocular safety and efficacy of an HSV-1 gD vaccine during primary and latent infection.
Nesburn AB; Ghiasi H; Wechsler SL
Invest Ophthalmol Vis Sci; 1990 Aug; 31(8):1497-502. PubMed ID: 2167298
[TBL] [Abstract][Full Text] [Related]
8. [Short-term therapeutic effect of an inactivated herpes simplex virus type 1 vaccine on herpes simplex keratitis].
Zhang YQ
Zhonghua Yan Ke Za Zhi; 1983 Nov; 19(6):339-42. PubMed ID: 6327206
[No Abstract] [Full Text] [Related]
9. [Anti-herpetic vaccination by nasal route in rabbits].
Schillinger G
Ann Ocul (Paris); 1972 Aug; 205(8):941-51. PubMed ID: 4345394
[No Abstract] [Full Text] [Related]
10. Herpetic stromal keratitis-evidence for cell-mediated immunopathogenesis.
Metcalf JF; Kaufman HE
Am J Ophthalmol; 1976 Dec; 82(6):827-34. PubMed ID: 187060
[TBL] [Abstract][Full Text] [Related]
11. Experimental keratitis in rabbits by human HSV-1 variants: prevention and treatment.
Manservigi R; Incorvaia C; Di Luca D; Rotola A; Balboni PG; Sebastiani A; Rossi A; Cassai E
J Med Virol; 1990 Nov; 32(3):148-54. PubMed ID: 2177779
[TBL] [Abstract][Full Text] [Related]
12. [Mechanism of action of inactivated herpes vaccine in rabbits with chronic herpetic infections].
Barinskiĭ IF; Zaĭtseva NS; Krichevskaia EI; Slepova OS; Vinogradova VI
Vopr Virusol; 1977; (6):670-5. PubMed ID: 602145
[TBL] [Abstract][Full Text] [Related]
13. Protective immunity against herpetic ocular disease in an outbred mouse model.
Metcalf JF; Whitley RJ
Curr Eye Res; 1987 Jan; 6(1):167-71. PubMed ID: 3030641
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the humoral and cellular immune response after immunization with live, UV inactivated herpes simplex virus and a subunit vaccine and efficacy of these immunizations.
Cappel R
Arch Virol; 1976; 52(1-2):29-35. PubMed ID: 187150
[TBL] [Abstract][Full Text] [Related]
15. Precipitating antibody response to herpes simplex virus in rabbits after herpetic keratoconjunctivitis.
Mäntyjärvi R
Acta Pathol Microbiol Scand; 1965; 65(4):581-6. PubMed ID: 4286991
[No Abstract] [Full Text] [Related]
16. Hypothetical vaccination of the Dutch population with a herpes simplex virus vaccine: estimation of the profitability using a demographic projection model.
Bos CA
Vaccine; 1988 Aug; 6(4):309-14. PubMed ID: 2847437
[TBL] [Abstract][Full Text] [Related]
17. [Immunological study of experimental herpetic keratitis in rabbit - cellular and humoral immunity after re-infection herpes simplex virus (author's transl)].
Dokoh R
Nippon Ganka Gakkai Zasshi; 1981 Aug; 85(8):1094-103. PubMed ID: 7315637
[No Abstract] [Full Text] [Related]
18. [Immunological indices in the dynamics of the treatment and prevention of ocular herpes].
Semenova EI; Mal'khanov VB
Vestn Oftalmol; 1983; (3):45-7. PubMed ID: 6308874
[No Abstract] [Full Text] [Related]
19. Local periocular vaccination protects against eye disease more effectively than systemic vaccination following primary ocular herpes simplex virus infection in rabbits.
Nesburn AB; Slanina S; Burke RL; Ghiasi H; Bahri S; Wechsler SL
J Virol; 1998 Oct; 72(10):7715-21. PubMed ID: 9733807
[TBL] [Abstract][Full Text] [Related]
20. Induction of cell-mediated immunity in herpes simplex virus keratitis. Kinetics of lymphocyte transformation and the effect of antiviral antibody.
Meyers-Elliott RH; Chitjian PA
Invest Ophthalmol Vis Sci; 1980 Aug; 19(8):920-9. PubMed ID: 6250986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
